Head and neck squamous cell carcinomas (HNSCC) are characterized by a marked propensity for local invasion and spread to cervical lymph nodes, with distant metastases developing in 30-40% of cases. HPV-16 is an important risk factor for HNSCC. How HPV enhances susceptibility to HNSCC is not fully understood, but seems to involve cofactors. In this study, we examined the effect of the cooperation between HPV-16 and the tyrosine kinase receptor ErbB-2 on E-cadherin/catenin complex patterns and neoplastic transformation of human normal oral epithelial (NOE) cells. We report that overexpression of ErbB-2 or E6/E7 alone does not affect E-cadherin/catenin complex patterns nor does it induce cell transformation of NOE cells. In contrast, coexpression of E6/E7 and ErbB-2 downregulates E-cadherin and catenin expression. This is accompanied by cytoplasmic localization of E-cadherin, as well as nuclear translocation of a, b, and c-catenins. Furthermore, we demonstrate that E6/E7 cooperate with overexpressed ErbB-2 to induce tumor formation in nude mice and to upregulate cyclin D1 and c-myc expression. Our data suggest that E6/E7 cooperate with ErbB-2 in head and neck carcinogenesis, at least in part, via the conversion of b-catenin from a cell adhesion to a nuclear function, that is, to act as a potential transcriptional regulator. This conversion leads to the upregulation of cyclin D1, c-myc and other oncoproteins necessary for alteration of the E-cadherin/catenin complex and cell transformation of NOE cells.
Introduction
In North America, head and neck (HN) cancer is the sixth most common cancer, in both males and females (Forastiere et al., 2001) . More than 90% of HN cancers are squamous cell carcinomas (SCC) (Wong et al., 1996) . Several tyrosine kinase receptors have been associated with human carcinogenesis, including the ErbB tyrosine kinase family (Riese and Stern, 1998; Tzahar and Yarden, 1998) . The ErbB family of receptors is comprised of EGF-R (ErbB-1), ErbB-2, ErbB-3, and ErbB-4; the four ErbB receptor members form homo-and heterodimer complexes upon activation by a family of EGF-like ligands thereby stimulating their kinase activity and generating intracellular signals (Riese and Stern, 1998; Tzahar and Yarden, 1998) . Constitutive stimulation of these pathways through autocrine mechanisms has been associated with several types of human cancers (Klapper et al., 2000) . ErbB-2 is the family member most closely implicated in human cancer, where it is overexpressed in about 30% of carcinomas including HNSCC (Xia et al., 1999; Yu and Hung, 2000) .
Several studies reported that chronic infection with high-risk human papillomavirus (HPV) type 16 and 18 could promote HN carcinogenesis (Franceschi et al., 1996; Gillison et al., 1999 Gillison et al., , 2000 . Two viral oncoproteins of HPV 16 and 18, E6 and E7, contribute to tumor progression by inactivating the p53 and retinoblastoma tumor suppressor products, respectively (Scheffner et al., 1993; Galloway and McDougall, 1996; Rapp and Chen, 1998) . E6 facilitates the degradation of p53 through its association with an accessory protein, E6-AP, a component of the ubiquitin proteolytic pathway (Scheffner et al., 1993) . E7 proteins of the high-risk types bind to Rb (Dyson et al., 1989) , as well as to other pocket proteins, such as p107 and p130 (Dyson et al., 1992) , leading to altered activities of these cell-cycle regulators. The E6 proteins from the low-risk viruses fail to abrogate p53 functions, while the low-risk E7 proteins bind Rb with substantially reduced affinity (Scheffner et al., 1994) . These differences can likely explain the lack of association of the low-risk types with malignancy.
HN cancers are characterized by local invasiveness and a propensity for dissemination to cervical lymph nodes. Tumor invasion is a complex process that requires active interactions between the invading cell and the extracellular matrix (ECM) and other stromal elements (Nelson et al., 2000) . At least three coordinated processes are necessary for invasion: (1) changes in cellcell and cell-matrix adhesion; (2) degradation of the ECM; and (3) cell migration. Cell-cell adhesion proteins are greatly involved in these processes. The epithelial cadherin (E-cadherin) glycoprotein is a major cell-cell adhesion molecule that connects epithelial cells via homotypic calcium-dependent interactions (Takeichi, 1990 ). E-cadherin-mediated cell adhesion requires intracellular attachment of this glycoprotein to the actin cytoskeleton (Ozawa et al., 1989) . Cadherins associate with the cytoskeleton through cytoplasmic interactions with catenins: a-catenin (102 kDa), b-catenin (88 kDa), and g-catenin (plakoglobin) (80 kDa) (Ozawa et al., 1989; Ozawa and Kemler, 1992) . E-cadherin/catenin members of the cell-cell adhesion family have been shown to be downregulated and in some cases, this altered expression is associated with a malignant and invasive phenotype in upper aerodigestive tract cancers (Ninomiya et al., 2000) .
To study the role of ErbB-2 and E6/E7 of HPV on cell-cell adhesion and cell transformation of human HN carcinogenesis, we developed normal HN epithelial cells (of oral origin) expressing ErbB-2 and/or E6/E7. We show that overexpression of ErbB-2 receptor or expression of E6/E7 of HPV alone does not affect E-cadherin/ catenin expression patterns or promote cell transformation of normal HN epithelial cells; in contrast, both processes are deregulated by E6/E7 and ErbB-2 in normal epithelial cells of the HN.
Results

Growth characteristics of cultured oral epithelial cells
We established primary epithelial cells from explants of fresh human gingiva and soft palate obtained from two HN cancer patients undergoing surgery (Al Moustafa et al., 2002a) . These cells named NOE, for normal oral epithelial cells, were established in keratinocyte serumfree (KSF) medium with supplement (see Methods). More than 95% of these primary normal cells displayed an epithelial morphology and demonstrated doubling times of approximately 5 days, being shorter in early passages than late passages, prior to senescence after approximately 10 passages. We did all our experiments between five and eight passages. We demonstrated earlier that NOE cells express keratins 13, 14, 15, 18, and 19 (Al Moustafa et al., 2002a) . Western blot ( Figure 1a ) and immunostaining (data not shown) revealed that NOE cells also express E-cadherin, a-, b, and g-catenin. Furthermore, these cells express detectable levels of EGF-R, ErbB-2, ErbB-3, and ErbB-4 receptors (Figure 1b) . Figure 1 (a) Western blot analysis of E-cadherin, a-, b-, and gcatenin expression in NOE, NOE-AP2, and NOE-ErbB-2 cells. The overexpression of ErbB-2 in NOE cells does not affect E-cadherin, a-, b-and g-catenin expression patterns compared to NOE and NOE-AP2 cells. (b) Western blot analysis of EGF-R (ErbB-1), ErbB-2, ErbB-3, and ErbB-4 receptor expression in the NOE, NOE-AP2, and NOE-ErbB-2 cells. NOE-ErbB-2 cells express the same level of EGF-R, ErbB-3, and ErbB-4 as NOE and NOE-AP2 cells, but show higher levels of ErbB-2 expression as expected. (c) Immunoprecipitation with anti-EGF-R, ErbB-2, ErbB-3, and ErbB-4 antibodies followed by Western blot with antiphosphotyrosine in NOE-AP2 and NOE-ErbB-2 cells. The overexpression of ErbB-2 receptor in NOE cells (NOE-ErbB-2) results in the constitutive activation of this receptor as shown by the greater quantity of the phosphorylated form of ErbB-2 in this cell line than in NOE-AP2 cells. In parallel, the activation of ErbB-2 induced tyrosine phosphorylation of EGF-R, ErbB-3, and ErbB-4 probably by heterodimerization in NOE-ErbB-2 cells. Notice that the phosphorylated form of ErbB-2 is present in greater amounts than the phosphorylated forms of EGF-R, ErbB-3, and ErbB-4 in NOEErbB-2 cells when compared with NOE-AP2 control cells. (d) Western blot analysis of E-cadherin, a-, b-, and g-catenin expression in NOE-E6/E7, NOE-E6/E7-AP2, and NOE-E6/E7-ErbB-2 cells. E6/E7 cooperate with ErbB-2 to induce downregulation of E-cadherin, a-, b-, and g-catenin expression; whereas, E6/E7, E6/E7-AP2, or ErbB-2 (a) alone does not affect the expression of E-cadherin, a-, b-, and g-catenin. For Western blot analysis, 30 mg of whole-cell extract was loaded onto a 7.5% SDS-PAGE gel and immunoblotted with anti-E-cadherin, -a-, -b-, -gcatenin, -ErbB-2, -ErbB-3, -ErbB-4, and -GAPDH antibodies; for immunoprecipitation, 200 mg of proteins were immunoprecipitated with anti-EGF-R, anti-ErbB-2, anti-ErbB-3, and anti-ErbB-4 antibodies, followed by Western blot with antiphosphotyrosine as indicated in Materials and methods
Effects of ErbB-2 overexpression in NOE cells
To study the role of ErbB-2 overexpression in HN carcinogenesis, we utilized a polyclonal population of NOE cells stably transduced with a bicistronic retrovirus, which coexpresses both ErbB-2 and enhanced green fluorescent protein (NOE-ErbB-2 and its control, NOE-AP2). As shown in Figure 1b , NOE-ErbB-2 overexpress ErbB-2 receptor by comparison with NOE-AP2; this overexpression resulted in constitutive activation of this receptor, as shown by phosphotyrosine content in NOE-ErbB-2 cells (Figure 1c) . The activation of ErbB-2 induced tyrosine phosphorylation of EGF-R, ErbB-3, and ErbB-4 probably by heterodimerization in NOE-ErbB-2 cells ( Figure 1c) . Next, we examined the effects of ErbB-2 overexpression on the E-cadherin/ catenin complex as well as cell transformation in NOEErbB-2 and NOE-AP2 cells. By Western blotting and immunostaining, we found that ErbB-2 did not affect protein expression and localization of E-cadherin/ catenin complex in NOE-ErbB-2 cells in comparison with NOE-AP2 ( Figure 1a ; see below). In parallel, there was no evidence of cellular neoplastic transformation by overexpression of ErbB-2, since the NOE-ErbB-2 and NOE-AP2 cells were unable to form colonies in soft agar or tumors in nude mice after 3 weeks and 3 months, respectively (see below).
Deregulation of E-cadherin/catenin patterns and cell transformation induced by E6/E7 and ErbB-2 in NOE cells
To examine the effect of E6/E7 expression of HPV type 16 and ErbB-2 overexpression on E-cadherin/catenin patterns and cell transformation in NOE cells, these cells were immortalized with HPV 16 E6/E7 open reading frames (ORFs) using a recombinant retroviral system as described by Halbert et al. (1991) . Positive cells were then selected in presence of the G418 selection marker. The HPV-infected cells showed minimal response to G418 treatment, while the normal control cells died within 4 days and PLXSN control cells underwent senescence after 10 passages. The E6/E7-immortalized cells, which displayed an epithelial morphology, demonstrated doubling times of approximately 3 days and were passaged weekly for more than 10 months. In contrast, the normal control and PLXSN-transduced cells senesced by the tenth passages.
Next, we transduced the E6/E7-immortalized cells, in early passage, with a bicistronic retrovirus that coexpresses both ErbB-2 and enhanced green fluorescent protein (GFP-ErbB-2 and its control GFP-AP2). We termed these cells NOE-E6/E7, NOE-E6/E7-AP2, and NOE-E6/E7-ErbB-2. We found that the coexpression of E6/E7 and ErbB-2 induce downregulation of E-cadherin/catenin complex of NOE cells (Figure 1d ), whereas ErbB-2 or E6/E7 alone did not affect the E-cadherin/ catenin expression ( Figure 1a and d, respectively). We next investigated the localization of E-cadherin, a-, b-, and g-catenins using immunofluorescent staining in NOE-E6/E7-AP2 and NOE-E6/E7-ErbB-2. NOE-E6/ E7-ErbB-2 cells showed less membrane staining, with a diffuse cytoplasmic distribution of E-cadherin, and a nuclear and cytoplasmic localization of a-, b-and gcatenins ( Figure 2a ). In contrast, E6/E7 or ErbB-2 alone did not affect the localization of E-cadherin/catenins in NOE cells (Figure 2a and b) . Furthermore, E6/E7 and Figure 2 Immunofluorescence analysis of ErbB-2, E-cadherin, a-, b-, and g-catenin localization in NOE-E6/E7-AP2 and NOE-E6/ E7-ErbB-2 cells (panel a), and in NOE-AP2 and NOE-ErbB-2 cells (panel b). Panel a: For NOE-E6/E7-AP2 cells, low levels of ErbB-2 are expressed, while E-cadherin expression is strongly localized to the plasma membrane and a-, b-, g-catenin to the membrane undercoat (arrows). For NOE-E6/E7-ErbB-2 cells, high levels of ErbB-2 expression are seen, E-cadherin has less membrane staining, with a diffuse cytoplasmic distribution, while a-, b-, and g-catenin expression is delocalized from the membrane undercoat into the nucleus and some parts of the cytoplasm (arrows) when compared to NOE-E6/E7-AP2 cells. Panel b: NOE-AP2 cells express low levels of ErbB-2, whereas E-cadherin expression is localized only in the membrane (arrows) and a-, b-, g-catenin are localized only on the membrane undercoat (arrows). NOE-ErbB-2 cells express high levels of ErbB-2; however, the expression patterns of E-cadherin and a-, b-, g-catenin are identical to those of NOE-AP2 cells. We can see some nonspecific staining in NOE-AP2 and NOE-ErbB-2 cell (Panel b) due to some senescent cells
Cooperation of E6/E7 and ErbB-2 in malignant cell transformation
A-E Al Moustafa et al ErbB-2 together induced cell transformation of NOE cells; consequently, about 30% of NOE-E6/E7-ErbB-2 cells were able to form colonies in soft agar ( Figure 3 ) and tumors in nude mice (data not shown) after 2 to 3 weeks, respectively. In contrast, NOE-E6/E7 and NOEErbB-2 cells were unable to grow in soft agar (Figure 3 ) or to form tumors in nude mice (data not shown). The effect of E6/E7/ErbB-2 combined in NOE cells is likely to be independent of p53 since ErbB-2 does not significantly accentuate the downregulation of p53 by E6/E7 (Figure 4) . Histology of the tumors confirmed the presence of a high-grade malignancy ( Figure 5a) ; we also found that these tumors overexpressed ErbB-2 using immunohistochemistry (Figure 5b ), and expressed E6/E7 by RT-PCR analysis (data not shown). Furthermore, we confirmed the effect of E6/E7/ErbB-2 cooperation on cell transformation and tumor formation in nude mice using another human NOE cell line and mice normal embryonic fibroblast (NEF) cell line. We injected a total of 30 nude mice with two NOE (2 and 8) and one NEF cell lines and also these same cell lines expressing E6/E7, ErbB-2, and E6/E7/ErbB-2 together. A total of 11 mice injected with cells (NOE and NEF) expressing E6/E7/ErbB-2 developed tumors within 10 days after injection (Table 1) . However, we killed the mice injected with NOE-E6/ E7-ErbB-2 cells within 1 month after injection because tumor volumes were larger than 1 cm 3 . In addition, mice injected with NEF-E6/E7 and NEF-E6/E7-ErbB-2 cells developed tumors o0.5 cm 3 and X1.0 cm 3 , respectively, within 10 days. The tumors formed by NEF-E6/E7 cells were expected since the transforming ability of E6/E7 of HPV 16 in mice has been confirmed by the use of transgenic mouse models (Eckert et al., 2000) .
E6/E7/ErbB-2 cooperation induced overexpression of cyclin D1 and c-myc
Earlier studies reported that cyclin D1 and c-myc are the targets of the nuclear b-catenin, via interaction with Tcell factor (Tcf) or lymphoid enhancer factor (Lef) family of transcription factors (Shtutman et al., 1999; Lin et al., 2000) . However, cyclin D1 has been shown to be required for the cell transformation induced by rat ErbB-2, that is, the Neu oncogene; this interaction between Neu and cyclin D1 is mediated by E2F-1, a transcription regulator (Lee et al., 2000) . To determine if cyclin D1 and c-myc are targets of E6/E7/ErbB-2 cooperation in NOE cells, we examined the expression of cyclin D1 and c-myc in NOE, NOE-AP2, NOE-ErbB-2, NOE-E6/E7, and NOE-E6/E7-ErbB-2 cells. We found that cyclin D1 and c-myc (Figure 6 ) are upregulated in NOE-E6/E7-ErbB-2 cells by comparison with NOE, NOE-AP2, NOE-ErbB-2, or NOE-E6/E7 cells.
Discussion
In this study, we examined the role of ErbB-2 and E6/E7 of HPV type 16 on regulation of E-cadherin/catenin complex patterns and cell transformation in normal oral epithelial cells. Overexpression of the type I tyrosine kinase receptor ErbB-2 has been implicated in the etiology of at least 30% of human carcinomas including breast and HN cancer. Agents that inhibit ErbB-2 receptor are now used as therapeutic tools for the treatment of human cancer (Yu and Hung, 2000) . In parallel, HPVs are etiologically linked to about 25% of oral and HN cancers (Ke et al., 1999; Niv et al., 2000) . All HPV-transformed cancer tissues express two HPVencoded oncoproteins, E6 and E7. We established cell lines from NOE cells (Al Moustafa et al., 2002a) in order to directly examine the effect of overexpression of ErbB-2 and HPV infection on HN carcinogenesis. Tumors o0.5 cm 3 within 10 days Figure 6 Western blot analysis of cyclin D1 and c-myc expression in NOE, NOE-AP2, NOE-ErbB-2, NOE-E6/E7, and NOE-E6/E7-ErbB-2 cells. NOE, NOE-AP2, NOE-ErbB-2, and NOE-E6/E7 cells express low levels of cyclin D1, whereas NOE-E6/E7-ErbB-2 cells demonstrate a high expression of cyclin D1 (arrow). NOE, NOE-AP2, and NOE-ErbB-2 cells express low levels of c-myc, while NOE-E6/E7 and NOE-E6/E7-ErbB-2 cells express moderate and high levels of c-myc, respectively. Thus, E6/E7 cooperate with ErbB-2 to upregulate cyclin D1 and c-myc expression in comparison with AP-2 (empty retro-vector), E6/E7, or ErbB-2 alone in NOE cells
Cooperation of E6/E7 and ErbB-2 in malignant cell transformation A-E Al Moustafa et al
We first demonstrated that the overexpression of ErbB-2 receptor alone did not affect E-cadherin/catenin complex patterns and cell transformation of the NOE cells. Previously, Orr et al. (2000) reported that overexpression of ErbB-2 receptor was not sufficient by itself to induce changes in chemosensitivity in human normal mammary epithelial (NME) cells. Furthermore, our own work showed that overexpression of ErbB-2 alone did not affect expression of either E-cadherin or a-, b-, gcatenin, and did not induce cell transformation of human NME cells (Al Moustafa et al., unpublished data). In contrast, several studies have reported that rat ErbB-2 (Neu) induces cell transformation in vitro and mammary adenocarcinomas in transgenic mice with high frequency (Xie et al., 1995; Guy et al., 1996) . Interestingly, ErbB-2 has been shown to cooperate with inactivated p53 (which is a target for E6) in mammary carcinogenesis in transgenic mice (Li et al., 1997) .
Here, we report that ErbB-2 was constitutively tyrosine phosphorylated in the absence of growth factor in NOE-ErbB-2, but not in NOE-AP2 cells. In this case, the constitutive activation of ErbB-2 seems to be the direct result of the overexpression of ErbB-2 receptor in NOE-ErbB-2 cells. Furthermore, we demonstrated that the overexpression of ErbB-2 leads to constitutive activation of this receptor, as previously reported (Riese and Stern, 1998), which in turn induced tyrosine phosphorylation of EGF-R, ErbB-3, and ErbB-4 probably by heterodimerization in NOE-ErbB-2 cells. However, the active form of ErbB-2 receptor was not sufficient to induce E-cadherin/catenin complex alteration and cell transformation. In contrast, the overexpression of ErbB-2 downregulated E-cadherin expression in human mammary epithelial cell line MTSV1-7 immortalized by simian virus 40 (SV40) large tumor (T) antigen (D'souza and Taylor-Papadimitriou, 1994) . Thus, the downregulation of E-cadherin expression observed by these authors in MTSV1-7 may be related to the cooperation between ErbB-2 receptor and large T of SV40.
Several studies reported that HPV type 16 and 18 infection promote HN carcinogenesis (Franceschi et al., 1996; Gillison et al., 1999 Gillison et al., , 2000 . Two viral oncoproteins of HPV 16 and 18, E6 and E7, could facilitate tumor progression by inactivating the p53 gene and retinoblastoma tumor suppressor gene products (Scheffner et al., 1993; Galloway and McDougall, 1996; Rapp and Chen, 1998) . These viral oncoproteins, E6 and E7, are capable of immortalizing primary human keratinocytes from upper respiratory tract epithelial (McDougall, 1994) and disrupting cell-cycle regulatory pathways in the genetic progression of HNSCC (Sidransky, 1995; Forastiere et al., 2001) . HN cancers are characterized by local invasiveness and a propensity for dissemination to cervical lymph nodes. Both the E-cadherin/catenin complex and ErbB-2 receptor are greatly involved in these processes. Using microarray analysis, we recently reported that E-cadherin/catenin expression is downregulated in HNSCC cells in comparison to matched NOE cells from the same patients (Al Moustafa et al., 2002a) . Wilding et al. (1996) showed that E6/E7 of HPV type 16 did not affect E-cadherin expression and localization, whereas E6/E7 caused a very slight redistribution of a-, b-, and g-catenin from the undercoat membrane to the cytoplasm without affecting the expression levels of these proteins in normal human keratinocytes. We developed NOE and E6/E7-immortalized cells to study the effects of ErbB-2 and HPV infection on E-cadherin/catenin complex patterns and cell transformation. In this study, we showed that E6/E7 did not affect the expression and localization of the Ecadherin/catenin complex in human NOE cells. We confirmed our data by Western blot and immunofluorescent staining. In contrast, we demonstrated that E6/E7 cooperate with the activated form of ErbB-2 to induce downregulation of the E-cadherin/catenin complex in NOE cells. We also showed that E-cadherin/catenin localization is affected by E6/E7 and ErbB-2 cooperation. NOE-E6/E7-ErbB-2 cells showed less membrane staining, with a diffuse cytoplasmic distribution of Ecadherin, and a nuclear and cytoplasmic localization of a-, b-, and g-catenins. Also, NOE-E6/E7-ErbB-2 cells were able to form tumors in nude mice and colonies in soft agar. This effect is likely to be independent of p53 since ErbB-2 does not significantly accentuate the downregulation of p53 by E6/E7 (Figure 4) .
Earlier studies reported that b-catenin-E-cadherin association is critically important for the maintenance of tight cell-cell contacts. When released from E-cadherin, uncomplexed b-catenin is rapidly degraded by cytosolic proteasomes (Gumbiner et al., 1988; Orford et al., 1997; Salomon et al., 1997) . Failure to properly degrade bcatenin, primarily attributable to impairment in its ubiquitination, results in b-catenin accumulation and migration to the nucleus where, via interaction with the Tcf/Lef family of transcription factors, it can upregulate transcription of a number of oncogenes, including c-myc and cyclin D1 (He et al., 1998; Shtutman et al., 1999; Lin et al., 2000) . We were able to confirm the translocation of b-catenin from the cytoplasm to the cell nucleus in E6/E7/ErbB-2 transformed NOE cells via Western blotting of the nuclear and cytoplamic protein extracts (data not shown). Furthermore, cyclin D1 has been shown to be required for the cell transformation induced by rat ErbB-2 homologue, Neu; this interaction between Neu and cyclin D1 is mediated through E2F-1, a transcription regulator (Lee et al., 2000) . We report, for the first time, that cyclin D1 and c-myc are targets of the cooperation between E6/E7 and ErbB-2 by comparison with E6/E7 alone and ErbB-2 alone in NOE cells. In addition, we observed that coexpression of E6/E7 and ErbB-2 in cyclin D1 knockout (À/À) fibroblast cells failed to induce cell transformation and tumor formation compared to cyclin D1 wild type ( þ / þ ) (Al Moustafa et al., in preparation) . Therefore, E6/E7/ ErbB-2 cooperation seems to function specifically in the human epithelial HN cell transformation pathway and does not affect all cell types since it failed to transform human NME cells (data not shown). Thus, the transformation and subsequent tumor formation observed in NOE-E6/E7-ErbB-2 cells are probably the result of the nuclear accumulation of b-catenin, and possibly a-catenin in the presence of cyclin D1 expression. The altered expression and relocation of these proteins follows the cooperation of E6/E7 with ErbB-2 signaling.
In conclusion, we demonstrated that coexpression of E6/E7 and ErbB-2 induces b-catenin/cyclin D1 interaction in human NOE cells; this finding provides a new basis for understanding the mechanisms of HN, as well as cervical carcinogenesis, which is also positive for E6/ E7 of HPV and overexpresses ErbB-2. Furthermore, our data will open a new therapeutic direction by cotargeting the E6/E7/ErbB-2 pathways in HN and cervical cancer.
Materials and methods
Tissue samples and primary oral epithelial cell culture
Normal oral tissues were obtained with informed consent from areas surrounding HN cancers in patients undergoing surgery. The biopsies were macroscopically normal. The specimens were washed immediately in cold, sterile phosphate-buffered saline (PBS). After removing excess and damaged epithelium and stromal tissue, the healthy specimen was cut into small pieces and incubated for 10 min at 371C in 0.05% trypsin in 0.53 mM EDTA (Gibco/BRL). Surface epithelium was mechanically separated to dissociate the cells into a single cell suspension. The NOE cells were collected after centrifugation and resuspended in mammary epithelial growth medium (MEGM, Clonetics). Cells were seeded on plastic dishes (Falcon) and fed every 48 h. After 1 week, we replaced the MEGM medium with KSF medium supplemented with 5 ng/ ml heregulin and 5 mg/100 ml of bovine pituitary extract (BPE) (Gibco/BRL).
Immortalization of NOE cells with E6/E7 genes of HPV type 16
NOE cells at 60% confluence were transfected with E6/E7 ORFs using a recombinant retroviral system as previously described (Halbert et al., 1991) . Briefly, HPV E6/E7 ORFs were cloned into the murine-based retroviral vector PLXSN. The constructs were transfected into a packaging cell line PA317 and recombinant retrovirus collected in the supernatant. The resulting PLXSN virus was used to infect the early passage NOE cells. Cells were selected with G418 at 200 mg/ml and passaged in culture. Normal control cells and normal cells transduced with PLXSN vector were also treated with G418. Over 95% of the E6/E7-immortalized cells were healthy after the G418 treatment. NOE-E6/E7 cells were trypsinized and passaged twice, while maintained on G418. The NOE normal cells died after around 4 days of treatment with G418; whereas PLXSN-transduced cells underwent senescence after approximately 10 passages. The NOE-E6/E7 cells were subsequently maintained in long-term culture with KSF medium without supplement.
Retrovector construction and stable overexpression of ErbB-2 in NOE and NOE-E6/E7 cells The AP2-ErbB-2 retrovector construction was generated as follows: the 4.1 kb XhoI fragment of PLXSN-ErbB-2, containing the complete ErbB-2 cDNA, was subcloned into the AP2 retrovector (Galipeau et al., 1999) . Recombinant retroparticles were generated by stable transfection of the 293GPG packaging cell line, with subsequent production of high titer retrovirus as described (Yen et al., 2002) . NOE and NOE-E6/E7 cells were transduced with AP2-ErbB-2 retroviral particles. Cells were plated at a density of 2 Â 10 4 cells per well in a 24-well plate with 50 ml of concentrated retrovirus added to the growth media. The following day, the media was replaced with fresh media containing virus. Transductions were repeated daily for 3 consecutive days. Stably transduced cells were expanded, and flow cytometric analysis was performed with an Epics XL/MCL Coulter analyzer to verify gene transfer efficiency as measured by GFP fluorescence.
Western blot and immunoprecipitation analysis
This assay was performed as previously described (Osborn et al., 1989; Al Moustafa et al., 1999 , 2002b ) but in the experiments described here, anti-E-cadherin, a-catenin, bcatenin, g-catenin, and anti-EGF-R (clone 13) monoclonal antibodies (mAbs) (Bio/Can Scientific); anti-c-myc (Ab-1, Calbiochem), anti-ErbB-2 mAb (Ab-3, Oncogene Science), anti-GAPDH (clone 6C5, Cedarlane), and antiactin (clone C4, Roche Diagnostics) mAbs; anti-ErbB-3, anti-ErbB-4, anticyclin D1 antisera (sc-285, sc-283, sc-717, Santa Cruz Biotechnology Inc.), and p53 (Ab-5, Calbiochem) were used for the assays. For immunoprecipitation, 200 mg of proteins were immunoprecipitated with anti-EGF-R mAb (clone 13, Bio/Can Scientific), anti-ErbB-2 mAb (Ab-3, Oncogene Science), anti-ErbB-3 mAb (sc-415, Santa Cruz Biotechnology Inc.), and anti-ErbB-4 antisera (sc-283, Santa Cruz Biotechnology Inc.). Immunoprecipitated samples were then blotted on nitrocellulose membrane and detected with antibody against phosphotyrosine (4G10, Upstate Biotechnology). Although, cells used for the tyrosine phosphorylation assay were seeded in KSF medium without heregulin 24 h prior to assay.
Immunofluorescence analysis
NOE, NOE-AP2, NOE-ErbB-2, NOE-E6/E7, and NOE-E6/ E7-ErbB-2 cells were seeded on coverslips for 2 days at a density of 50 000 cells/35 mm dish. The cells were rinsed with PBS and fixed with 3% (w/v) paraformaldehyde in PBS for 5 min, followed by an incubation in precooled methanol (À201C) for 15 min. The cells were then rinsed with PBS and blocked with 2% BSA, 2% normal goat serum, and 0.2% gelatin in PBS. The cells were then incubated with the following primary antibodies: anti-E-cadherin, a-, b-, and gcatenin mAbs (Bio/Can Scientific), or ErbB-2 (Ab-3) for 1 h at room temperature. All antibody dilutions were made in blocking solution. After three washes with 0.2% BSA in PBS, the cells were incubated with appropriate secondary antibodies conjugated to Texas Red (Jackson Immunoresearch Laboratories) for 30 min. The coverslips were then washed with PBS and mounted with Airvol (Air Products and Chemicals, Inc.), and viewed with a Zeiss Axiophot fluorescent microscope equipped with 63 Â plan apochromat objectives and selective filters. Images were photographed using Kodak T-Max 400 film.
Soft agar growth assay 2 Â 10 3 cells of NOE, NOE-AP2, NOE-ErbB-2, NOE-E6/E7, and NOE-E6/E7-ErbB-2 were placed in KSF medium containing 0.4% agar and plated over a layer of KSF medium containing 0.7% agar. The cultures were examined every 1-2 day for 3 weeks.
Growth of tumor xenografts in nude mice
Subconfluent NOE, NOE-AP2, NOE-ErbB-2, NOE-E6/E7, and NOE-E6/E7-ErbB-2 cells were resuspended in PBS and injected subcutaneously in the flank region (2 Â 10 6 /0.2 ml) of BALB/c (nu/nu) mice. The experimental animals were cared for in accordance with McGill University Animal care guidelines.
Histology and immunohistochemistry analyses
For histological analysis, tumors were excised and fixed in neutral-buffered formalin 10% (EM Science, NJ, USA) overnight at room temperature prior to being embedded in paraffin. Embedded tissues were sectioned at a thickness of 5 mm and stained with hematoxylin and eosin (H&E). For immunoperoxidase staining of p185-ErbB-2, paraffin-embedded tumour sections were labelled using the avidin-biotin method (Vector Laboratories, Inc.). Endogenous peroxidase activity was quenched by incubation in 1.5% hydrogen peroxide for 30 min at room temperature. Sections were immersed in 10 mM sodium citrate buffer (pH 6.0) and subjected to heat-induced antigen retrieval. To block binding of endogenous biotin, sections were incubated with an endogenous avidin-biotin-blocking kit (Zymed Laboratories, Inc.) according to the manufacturer's instructions. The sections were then incubated with anti-ErbB-2 mAb (TAB 250, Zymed Laboratories, Inc.), a primary monoclonal antibody at a dilution of 1 : 100 overnight at 41C. After being rinsed extensively with PBS, the sections were incubated with the appropriate biotinylated secondary antibodies for 30 min at room temperature (Vector Laboratories, Inc.), followed by a 30-min incubation with the avidin-biotin-horseradish peroxidase complex (Vector Laboratories, Inc.) in PBS and then by final color development with diaminobenzidine substrate kit peroxidase (Vector Laboratories, Inc.). Negative control experiments were performed by omission of the primary antibody. Sections were then lightly counterstained with H&E and then analysed by conventional light microscopy and photographed with the use of Kodak color slides.
Reverse transcription (RT)-PCR analysis
RT-PCR amplification was performed using the following primer sets: E6, 5 0 -ATGCACCAAAAGAGAACTGCA-3 0 and 5 0 -TTACAGCTGGGTTTCTCTACG-3 0 ; E7, 5 0 -ATG-CATGGAGATACACCTACATTGCAT-3 0 and 5 0 -GTTTCT-GAGAACAG-ATGGGGCACAC-3 0 . Primers specific for GAPDH gene, 5 0 -GAAGGC-CATGCCAGTGAGCT-3 0 and 5 0 -CCGGGAAACTGTGGCGTGAT-3 0 , were used to control for the amounts of cDNA generated from each sample. Synthesis of the first-strand cDNA was carried out using a cDNA kit for RT-PCR (MBI Fermentas). One-fifth of the RT product was amplified for 30 cycles (1 min at 951C, 1 min at 581C, and 1 min at 721C) followed by an extension of 10 min at 721C. RT-PCR amplification products were analysed on a 1% agarose gel stained with ethidium bromide.
